Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-18

Clinical Trial Update: Xiidra vs. Xiidra + Dextenza Treatment for Dry Eye Disease [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Xiidra alone versus Xiidra plus Dextenza for dry eye disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextenza (Dexamethasone)
  • Xiidra (Lifitegrast)

Snippet

Sponsor: Eye Surgeons of Indiana | Conditions: Dry Eye Syndromes | Phase 4 | Status: TERMINATED